Tredje AP fonden Purchases Shares of 10,386 STERIS plc $STE

Tredje AP fonden acquired a new stake in STERIS plc (NYSE:STE) during the 4th quarter, Holdings Channel.com reports. The fund acquired 10,386 shares of the medical equipment provider’s stock, valued at approximately $2,633,000.

Other institutional investors and hedge funds also recently added to or reduced their stakes in the company. Board of the Pension Protection Fund acquired a new stake in shares of STERIS during the 4th quarter worth approximately $25,000. Harbor Investment Advisory LLC raised its stake in shares of STERIS by 115.4% during the 4th quarter. Harbor Investment Advisory LLC now owns 112 shares of the medical equipment provider’s stock worth $28,000 after buying an additional 60 shares during the period. Activest Wealth Management grew its stake in STERIS by 423.8% in the 4th quarter. Activest Wealth Management now owns 110 shares of the medical equipment provider’s stock valued at $28,000 after acquiring an additional 89 shares during the period. Cloud Capital Management LLC purchased a new stake in STERIS in the 3rd quarter worth $29,000. Finally, Geneos Wealth Management Inc. raised its position in STERIS by 416.0% during the first quarter. Geneos Wealth Management Inc. now owns 129 shares of the medical equipment provider’s stock worth $29,000 after acquiring an additional 104 shares during the period. 94.69% of the stock is currently owned by institutional investors and hedge funds.

Analysts Set New Price Targets

A number of analysts have recently issued reports on STE shares. Wall Street Zen upgraded shares of STERIS from a “buy” rating to a “strong-buy” rating in a report on Saturday. Weiss Ratings lowered STERIS from a “buy (b-)” rating to a “hold (c+)” rating in a research report on Thursday, April 16th. Finally, KeyCorp reduced their target price on STERIS from $291.00 to $269.00 and set an “overweight” rating on the stock in a research report on Wednesday, May 13th. Two analysts have rated the stock with a Buy rating and two have given a Hold rating to the company. According to data from MarketBeat.com, the company presently has an average rating of “Moderate Buy” and a consensus target price of $275.67.

STERIS Trading Up 0.7%

Shares of STERIS stock opened at $214.44 on Wednesday. The company has a market capitalization of $21.03 billion, a P/E ratio of 27.04 and a beta of 0.95. STERIS plc has a 1 year low of $195.14 and a 1 year high of $269.44. The company’s fifty day moving average is $218.81 and its two-hundred day moving average is $242.57. The company has a debt-to-equity ratio of 0.25, a quick ratio of 1.54 and a current ratio of 2.09.

STERIS (NYSE:STE) last released its quarterly earnings data on Monday, May 11th. The medical equipment provider reported $2.83 EPS for the quarter, missing analysts’ consensus estimates of $2.86 by ($0.03). STERIS had a return on equity of 14.15% and a net margin of 13.18%.The company had revenue of $1.59 billion for the quarter, compared to analysts’ expectations of $1.59 billion. During the same period in the prior year, the firm posted $2.74 EPS. The firm’s quarterly revenue was up 6.7% on a year-over-year basis. STERIS has set its FY 2027 guidance at 11.100-11.300 EPS. Analysts forecast that STERIS plc will post 11.18 earnings per share for the current year.

STERIS Announces Dividend

The business also recently declared a quarterly dividend, which will be paid on Friday, June 26th. Stockholders of record on Monday, June 8th will be given a dividend of $0.63 per share. The ex-dividend date of this dividend is Monday, June 8th. This represents a $2.52 annualized dividend and a dividend yield of 1.2%. STERIS’s dividend payout ratio (DPR) is presently 31.78%.

Insider Transactions at STERIS

In other news, Director Cynthia L. Feldmann sold 3,098 shares of the firm’s stock in a transaction dated Thursday, March 5th. The shares were sold at an average price of $237.21, for a total value of $734,876.58. Following the transaction, the director directly owned 705 shares in the company, valued at approximately $167,233.05. This trade represents a 81.46% decrease in their position. The transaction was disclosed in a filing with the SEC, which can be accessed through the SEC website. 1.07% of the stock is owned by insiders.

STERIS Company Profile

STERIS Corporation (NYSE: STE) is a global provider of infection prevention, contamination control and procedural products and services for the healthcare, life sciences, pharmaceutical and medical device industries. The company develops, manufactures and supports a broad portfolio of equipment and consumables designed to reduce risk of infection, maintain sterile environments and support critical clinical and manufacturing procedures.

Its offerings include sterilization and decontamination systems, instrument washers and washers-disinfectors, endoscope reprocessing solutions, surgical equipment and procedural disposables, and contamination-control products for cleanrooms and laboratories.